InnoCore’s technologies can be applied in several administration forms. Our SynBiosys® platform is compatible with state-of-the-art depot formulation technologies, like microspheres, microrods, microparticles and nanoparticles. The technology is also suitable for implants, fleece’s and for spray coating of implants, like coronary stents and other vascular devices. The InGell® technology is an advanced injectable gel drug depot system, offering un-paralleled retention and release of active pharmaceutical ingredients from a soft, localized drug depot. The InGell technology is available as a water-borne gel (hydrogel consisting of 75-90% of buffer) and a water-free gel (100% pure polymer, LQP).